دورية أكاديمية
أعرض في EDS

NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target.

التفاصيل البيبلوغرافية
العنوان: NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target.
المؤلفون: Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. l.s.jiwa-3@prinsesmaximacentrum.nl.; Department of Pathology, Utrecht University Hospital, Utrecht, The Netherlands. l.s.jiwa-3@prinsesmaximacentrum.nl., Meister MT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Martin E; Department of Reconstructive Surgery, Utrecht University Hospital, Utrecht, The Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Haveman LM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Meijers RWJ; Department of Pathology, Utrecht University Hospital, Utrecht, The Netherlands., Tops BBJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers/Location VUmc, Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, Utrecht University Hospital, Utrecht, The Netherlands., van Gorp JM; Department of Pathology, St. Antonius Hospital, Nieuwegein, The Netherlands., Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., van Belzen IAEM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Division Imaging and Cancer, Utrecht University Hospital, Utrecht, the Netherlands., Flucke U; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Kester LA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
المصدر: Acta neuropathologica [Acta Neuropathol] 2023 Jan; Vol. 145 (1), pp. 149-152. Date of Electronic Publication: 2022 Nov 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer Verlag
مواضيع طبية MeSH: Neurofibrosarcoma*/genetics , Nerve Sheath Neoplasms*/genetics , Nerve Sheath Neoplasms*/pathology , Neurofibromatosis 1*/genetics, Humans
References: Antonescu CR (2020) Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosomes Cancer 59:437–444. (PMID: 10.1002/gcc.22846)
Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15:731–747. (PMID: 10.1038/s41571-018-0113-0)
Cocco E, Schram AM, Kulick A, Misale S, Won HH, Yaeger R et al (2019) Resistance to TRK inhibition mediated by convergent MAPK pathway activation. Nat Med 25:1422–1427. (PMID: 10.1038/s41591-019-0542-z)
de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A et al (2022) MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus. Neuro Oncol. https://doi.org/10.1093/neuonc/noac165.
Dupain C, Harttrampf AC, Boursin Y, Lebeurrier M, Rondof W, Robert-Siegwald G et al (2019) Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine. Mol Ther 27:200–218. (PMID: 10.1016/j.ymthe.2018.10.022)
Hemming ML, Nathenson MJ, Lin JR, Mei S, Du Z, Malik K et al (2020) Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1. JCO Precis Oncol 4:79–90. (PMID: 10.1200/PO.19.00287)
Longo JF, Brosius SN, Znoyko I, Alers VA, Jenkins DP, Wilson RC et al (2021) Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep 11:5690. (PMID: 10.1038/s41598-021-85055-2)
Pemov A, Li H, Presley W, Wallace MR, Miller DT (2020) Genetics of human malignant peripheral nerve sheath tumors. Neurooncol Adv 2:i50–i61.
Somatilaka BN, Sadek A, McKay RM, Le LQ (2022) Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41:2405–2421. (PMID: 10.1038/s41388-022-02290-1)
Uusitalo E, Rantanen M, Kallionpää RA, Pöyhönen M, Leppävirta J, Ylä-Outinen H et al (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34:1978–1986. (PMID: 10.1200/JCO.2015.65.3576)
تواريخ الأحداث: Date Created: 20221104 Date Completed: 20230104 Latest Revision: 20230307
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9807516
DOI: 10.1007/s00401-022-02515-3
PMID: 36331594
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-0533
DOI:10.1007/s00401-022-02515-3